First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2013-07-21 05:34:01Open Document File Size: 992,23 KBShare Result on FacebookCityLondon / /CountryTurkey / France / Russia / Brazil / Australia / Portugal / Ukraine / South Africa / /Currencypence / / /FacilityCanary Wharf / / /IndustryTermpharmaceutical form / pharmaceutical and biological aspects / industrial container closure systems / printing / drug product / human and veterinary medicinal products / intrinsic physico-chemical properties / intermediate products / sponsor site / degradation products / chemical purity / manufacturing process / treatment of major depressive disorder / /MedicalConditionaluminium/polyvinylchloride blister / major depressive disorder / Depressive disorders / common mood disorder / Introduction Major Depressive Disorder / heat-sealed aluminium/polyvinyl chloride blister / hepatic injury / blister / animal spongiform encephalopathy agents / depression / significant CNS depression / /MedicalTreatmentantidepressant therapy / /OrganizationEuropean Medicines Agency / Commission of the European Communities / CHMP / /PersonTomas P Salmonson / / /PositionMajor / representative / /Productdiazepam / mirtazapine / fluoxetine / ACTH / /ProgrammingLanguageEC / /ProvinceOrStateSouth Dakota / /Technologypharmacokinetics / Laser / pharmacodynamics / /URLhttp /SocialTag |